Free shipping on all orders over $ 500

GSK4381406

Cat. No. M45110

All AbMole products are for research use only, cannot be used for human consumption.

GSK4381406 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

GSK4381406 is a first-in-class, orally active GPR35 agonist for studies related to inflammatory bowel disease (IBD).

Chemical Information
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related GPR/FFAR Products
GPR84 antagonist 8 

GPR84 antagonist 8 is a selective GPR84 antagonist.

ML191

ML-191 is an antagonist of GPR55.

CID1172084 

CID1172084 is a selective GPR55 agonist (EC50=0.16 μM).

ML 145 

ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM.

PSN 375963 hydrochloride 

PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK4381406 supplier, GPR/FFAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.